🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06391372
Active, not recruiting Phase 3

Effect of Local Estriol Treatment Before Vaginal Repair Surgery

NCT06391372 · tracked via the Priya Life Science Turkey tracker
Sponsor
Hatice Tukenmez Kurnaz
Phase
Phase 3
Started
2024-04-01
Last updated
2025-02-05

Condition(s) studied

Pelvic Organ ProlapsePelvic Floor DisordersMenopauseVaginal Atrophy

Investigational drug(s) / intervention(s)

estriol cream →

estriol cream: 1 g intravaginal estriol via applicator twice a week before going to bed for 4 weeks

Study summary

The aim of the study is to evaluate the effects of local estriol treatment applied before vaginal repair surgery on steroid receptors, inflammatory cell response, vascular, connective and nervous tissues in the vagina, and its effects on early postoperative period pelvic floor functions, satisfaction with the surgery and vaginal health.

Eligibility

Sex
FEMALE
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: -Postmenopausal women with a diagnosis of pelvic organ prolapse and an indication for vaginal repair surgery including colporrhaphy anterior and/or posterior surgery Exclusion Criteria: * Psychiatric and neurological disease that causes disability in mental and motor functions * receiving systemic/local hormone replacement therapy in the last three months * applying vulvar/local steroids for any reason within the last three months * receiving treatment for pelvic and/or lower genital tract infection in the last three months * history of malignancy * previous vaginal repair surgery with/without mesh

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara University Faculty of Medicine Ankara Turkey (Türkiye)

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06391372 on ClinicalTrials.gov ↗ ← All trials in Turkey